scholarly article | Q13442814 |
P50 | author | Apriliana Cahya Khayrani | Q52729698 |
Aung Ko Ko Oo | Q52729707 | ||
Akimasa Seno | Q52729719 | ||
Masaharu Seno | Q42407066 | ||
P2093 | author name string | Juan Du | |
Hiroshi Murakami | |||
Akifumi Mizutani | |||
Junko Masuda | |||
Tomonari Kasai | |||
Arun Vaidyanath | |||
Hafizah Mahmud | |||
Samah El-Ghlban | |||
Mami Asakura | |||
P2860 | cites work | Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin | Q28214310 |
Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases | Q72927459 | ||
Mechanisms and kinetics of liposome-cell interactions | Q73850582 | ||
Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2 | Q28216166 | ||
Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci | Q28237061 | ||
Chloride channel inhibition by the venom of the scorpion Leiurus quinquestriatus | Q28285616 | ||
Use of chlorotoxin for targeting of primary brain tumors | Q28288404 | ||
Efficient drug delivery of Paclitaxel glycoside: a novel solubility gradient encapsulation into liposomes coupled with immunoliposomes preparation | Q28543361 | ||
A restricted cell population propagates glioblastoma growth after chemotherapy | Q29615605 | ||
Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. | Q33784378 | ||
Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells | Q35953911 | ||
The liposomal formulation of doxorubicin | Q36049002 | ||
Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas | Q36289595 | ||
Chlorotoxin Fused to IgG-Fc Inhibits Glioblastoma Cell Motility via Receptor-Mediated Endocytosis | Q36469086 | ||
Identification of caveolin-1 as a potential causative factor in the generation of trastuzumab resistance in breast cancer cells. | Q36983366 | ||
Glioblastoma: Overview of Disease and Treatment | Q37441791 | ||
Chlorotoxin-Fc fusion inhibits release of MMP-2 from pancreatic cancer cells. | Q37543361 | ||
Receptor-Mediated Drug Delivery Systems Targeting to Glioma | Q37636271 | ||
Coordinate action of membrane-type matrix metalloproteinase-1 (MT1-MMP) and MMP-2 enhances pericellular proteolysis and invasion | Q37690802 | ||
New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression | Q37948607 | ||
Fc-fusion proteins: new developments and future perspectives. | Q38029985 | ||
Peptide therapeutics: current status and future directions | Q38275750 | ||
Overcoming the blood-brain tumor barrier for effective glioblastoma treatment | Q38384505 | ||
Glioblastoma: molecular pathways, stem cells and therapeutic targets | Q38393328 | ||
Effect of ligand density and PEG modification on octreotide-targeted liposome via somatostatin receptor in vitro and in vivo. | Q38757086 | ||
Temozolomide nanoparticles for targeted glioblastoma therapy | Q38902260 | ||
The impact of a chlorotoxin-modified liposome system on receptor MMP-2 and the receptor-associated protein ClC-3. | Q39003190 | ||
Remote loading of doxorubicin into liposomes by transmembrane pH gradient to reduce toxicity toward H9c2 cells | Q39021269 | ||
Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin | Q43824344 | ||
Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma | Q44800304 | ||
Practical Liposomal Formulation for Taxanes with Polyethoxylated Castor Oil and Ethanol with Complete Encapsulation Efficiency and High Loading Efficiency. | Q45338727 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | doxorubicin | Q18936 |
glioblastoma | Q282142 | ||
P577 | publication date | 2018-02-26 | |
P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
P1476 | title | Targeting Glioblastoma Cells Expressing CD44 with Liposomes Encapsulating Doxorubicin and Displaying Chlorotoxin-IgG Fc Fusion Protein. | |
P478 | volume | 19 |
Q92824230 | 4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer |
Q91782756 | Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules |
Q60951228 | Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives |
Q64989949 | Neuropilin-1 drives tumor-specific uptake of chlorotoxin. |
Q64095502 | Targeting Ovarian Cancer Cells Overexpressing CD44 with Immunoliposomes Encapsulating Glycosylated Paclitaxel |
Q60048595 | Therapeutic nanoplatforms and delivery strategies for neurological disorders |
Search more.